Enlitic, Inc. (ENL.AX)
| Previous close | 0.1450 |
| Open | 0.1450 |
| Bid | 0.1250 x N/A |
| Ask | 0.1700 x N/A |
| Day's range | 0.1300 - 0.1450 |
| 52-week range | 0.1200 - 1.0100 |
| Volume | |
| Avg. volume | 59,654 |
| Market cap | 11.464M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.9400 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.When Will Enlitic, Inc. (ASX:ENL) Become Profitable?
We feel now is a pretty good time to analyse Enlitic, Inc.'s ( ASX:ENL ) business as it appears the company may be on...
- GlobeNewswire
Enlitic® Announces New Version of Data Standardization Software
Enlitic accelerates roadmap with the release of Ensight™ 2.0Highlights Enlitic brings its development schedule forward by 18 months with the release of Ensight 2.0 (“Ensight”)Ensight expands the suite of available use cases through an integrated frameworkEnsight will continue to accelerate commercial traction in the second half of 2024 FORT COLLINS, Colo., May 24, 2024 (GLOBE NEWSWIRE) -- Enlitic, Inc., (ASX: ENL)(“the Company”), a leading innovator in data standardization, has released Ensight™
- GlobeNewswire
Enlitic® Announces Appointment of Steve Rankin as Chief Strategy Officer
Rankin to drive Enlitic’s product and market strategies for future growth.FORT COLLINS, Colo. and MELBOURNE, Australia, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enlitic, Inc., (ASX:ENL) a leading innovator in data standardization, today announced the appointment of Steve Rankin as Chief Strategy Officer, effective February 1, 2024. Rankin is an experienced healthcare leader with over 25 years’ experience in global medical imaging. He has a demonstrated track record of developing and executing successfu
